Cargando…

High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma

Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qinlei, Ge, Wenjie, Wang, Tongtong, Lan, Jiayi, Martínez‐Jarquín, Sandra, Wolfrum, Christian, Stoffel, Markus, Zenobi, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597026/
https://www.ncbi.nlm.nih.gov/pubmed/34505339
http://dx.doi.org/10.1002/anie.202107223
_version_ 1784600520024915968
author Liu, Qinlei
Ge, Wenjie
Wang, Tongtong
Lan, Jiayi
Martínez‐Jarquín, Sandra
Wolfrum, Christian
Stoffel, Markus
Zenobi, Renato
author_facet Liu, Qinlei
Ge, Wenjie
Wang, Tongtong
Lan, Jiayi
Martínez‐Jarquín, Sandra
Wolfrum, Christian
Stoffel, Markus
Zenobi, Renato
author_sort Liu, Qinlei
collection PubMed
description Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze multiple metabolites in single cells at a rate of 38 cells/minute. Multiple cell types (HEK‐293T, PANC‐1, CFPAC‐1, H6c7, HeLa and iBAs) were discriminated successfully. We found evidence for abnormal lipid metabolism in pancreatic cancer cells. We also analyzed gene expression in a cancer genome atlas dataset and found that the mRNA level of a critical enzyme of lipid synthesis (ATP citrate lyase, ACLY) was upregulated in human pancreatic ductal adenocarcinoma (PDAC). Moreover, both an ACLY chemical inhibitor and a siRNA approach targeting ACLY could suppress the viability of PDAC cells. A significant reduction in lipid content in treated cells indicates that ACLY could be a potential target for treating pancreatic cancer.
format Online
Article
Text
id pubmed-8597026
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85970262021-11-22 High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma Liu, Qinlei Ge, Wenjie Wang, Tongtong Lan, Jiayi Martínez‐Jarquín, Sandra Wolfrum, Christian Stoffel, Markus Zenobi, Renato Angew Chem Int Ed Engl Research Articles Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze multiple metabolites in single cells at a rate of 38 cells/minute. Multiple cell types (HEK‐293T, PANC‐1, CFPAC‐1, H6c7, HeLa and iBAs) were discriminated successfully. We found evidence for abnormal lipid metabolism in pancreatic cancer cells. We also analyzed gene expression in a cancer genome atlas dataset and found that the mRNA level of a critical enzyme of lipid synthesis (ATP citrate lyase, ACLY) was upregulated in human pancreatic ductal adenocarcinoma (PDAC). Moreover, both an ACLY chemical inhibitor and a siRNA approach targeting ACLY could suppress the viability of PDAC cells. A significant reduction in lipid content in treated cells indicates that ACLY could be a potential target for treating pancreatic cancer. John Wiley and Sons Inc. 2021-10-11 2021-11-08 /pmc/articles/PMC8597026/ /pubmed/34505339 http://dx.doi.org/10.1002/anie.202107223 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Liu, Qinlei
Ge, Wenjie
Wang, Tongtong
Lan, Jiayi
Martínez‐Jarquín, Sandra
Wolfrum, Christian
Stoffel, Markus
Zenobi, Renato
High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title_full High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title_fullStr High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title_full_unstemmed High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title_short High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
title_sort high‐throughput single‐cell mass spectrometry reveals abnormal lipid metabolism in pancreatic ductal adenocarcinoma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597026/
https://www.ncbi.nlm.nih.gov/pubmed/34505339
http://dx.doi.org/10.1002/anie.202107223
work_keys_str_mv AT liuqinlei highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT gewenjie highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT wangtongtong highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT lanjiayi highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT martinezjarquinsandra highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT wolfrumchristian highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT stoffelmarkus highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma
AT zenobirenato highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma